Consumer Health

Paediatric consumer health is performing well in 2023 for the second consecutive year, albeit at a much lower pace of current value growth than in 2022. Ireland witnessed a more intense season of common colds and viruses among children in 2022 as the…

In 2023, paediatric consumer health continues to witness a strong performance, with current value sales predicted to be higher than in the previous year. In the years following the pandemic, the increase spread of common viruses and lower levels of…

Paediatric consumer health is expected to see strong growth in current value terms in 2023, with most categories projected to post a positive performance in value and volume terms. Volume sales are benefiting from the increase in unit prices…

Growth in paediatric consumer health current value sales in 2023 is expected to surpass that recorded in 2022, as are volume growth rates for all product categories. This improvement is partly attributable to relatively high birth rates in Morocco,…

The sales performances recorded in each of the categories that comprise paediatric consumer health during 2023 were determined to some extent by the performances recorded in each of these categories in 2020, during the early stages of the COVID-19…

Over 2023, paediatric consumer health retail current value sales are expected to continue to grow healthily. On the other hand, retail volume development is projected to be marginal-to-moderate, with declines anticipated for paediatric acetaminophen…

In the United Arab Emirates, there is wide knowledge of consumer health, due to the diverse make-up of the population. However, there are a significant number of parents who continue to be hesitant to give children over-the-counter medications due to…

It is evident that the average consumer has become more health-conscious since COVID-19, as seen through transformations in ingredient-focused product development in dermatologicals, alongside the rise of natural remedies and botanical compositions…

Demand for paediatric consumer health remains strong and rising in 2023, driven by increasing attention to children’s overall health and wellbeing, and consistent consumer education in Vietnam. An increasing mindset of prevention is prompting some…

During 2023, sleep aids continued to benefit from the post- pandemic landscape of ongoing global economic instability, compounded by rampant inflation, which placed pressure on both middle- and low-income groups. As a result, consumers were forced to…

Sales of sleep aids are seeing more stable growth in 2023 after the peaks achieved in 2020-2021 when the pandemic created widespread anxiety and insomnia. Many people had to work from home and home-school their children during times of lockdown and…

Sleep aids is projected to post fast retail volume growth over 2023. The category saw spikes in demand in 2020 and 2021 as the stress and anxiety of the Coronavirus (COVID-19) pandemic increased the incidence of sleep disorders or complaints. While…

Demand for sleep aids is growing in 2023 to remain significantly above pre-pandemic levels. Although value growth can also be considered healthy, it falls short when compared to the remarkable figures observed in 2021, when the category experienced…

Sleep disorders were already in the spotlight after the outbreak of COVID-19, and demand for sleep aids rose, given the disruption to daily routines, coupled with long screen hours during the lockdowns. However, despite the easing of COVID-19…

Sleep disorders have increased in Colombia since the pandemic due to the increased incidence of mental health issues and anxiety, whether diagnosed or not. The country still faces barriers to timely attention and diagnosis of psychological and…

Sleep aids is expected to register moderate current value growth and a slight increase in volume sales in 2023. The war in Ukraine and the resulting energy crisis are pushing up average retail prices. While Danes are now much less concerned about the…

Demand for sleep aids remains high in 2023. Since the pandemic, an increase in sleep issues due to anxiety, depression, and stress, has spread among a large proportion of the French population. According to Euromonitor International’s Voice of the…

The key growth driver in sleep aids in terms of ingredients is melatonin. The variety and availability of products based on melatonin increased dramatically at the end of the review period. The launch of Procter & Gamble’s ZzzQuil Nature made a…

General anxiety related to economic uncertainty, the high cost of living and the war in Ukraine is improving the popularity of sleep aids in 2023. Many consumers are also back to hectic everyday lifestyles, with commuting, longer working hours and a…

Demand for sleep aids remains strong in 2023, with everyday lifestyle issues and security concerns leading to sleep issues. The COVID-19 pandemic had a very strong impact on sleep in Israel and caused a surge in sleep deprivation and insomnia, which…